Aβ42 in cerebrospinal fluid, in combination with p-tau and t-tau, is usually the globally accepted signature for the diagnosis of Alzheimer’s disease [45]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.